Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
675 N Saint Clair St
Galter 21-100
Chicago, IL 60611Phone+1 312-695-0990Fax+1 312-695-6189- Is this information wrong?
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1979
University of MinnesotaFellowship, Hematology and Medical Oncology, 1978- University of ChicagoResidency, Internal Medicine, 1973 - 1976
- University of ChicagoInternship, Internal Medicine, 1973 - 1974
University of Cincinnati College of MedicineClass of 1973
Certifications & Licensure
IL State Medical License 1974 - 2026
MN State Medical License 1976 - 1978- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACP) American College of Physicians, 2007
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL Start of enrollment: 2003 Oct 28
- A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma Start of enrollment: 2006 Apr 07
- Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma Start of enrollment: 2007 Feb 06
- Join now to see all
Publications & Presentations
PubMed
- A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen.Karmali, R., Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas Kl...> ;Blood Advances. 2024 Apr 9
- 2 citationsTwo-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001.Jeremy S Abramson, M Lia Palomba, Leo I Gordon, Matthew Lunning, Michael Wang, Jon Arnason, Enkhtsetseg Purev, David G Maloney, Charalambos Andreadis, Alison Sehgal, S...> ;Blood. 2024 Feb 1
- Checkpoint inhibitor myocarditis with preceding immunosuppression and tolerance of sequential anthracycline therapy.Grewal, N., Akhter, N., Maning, J., Gordon, L.> ;BMJ Case Reports. 2024 Jan 10
- Join now to see all
Abstracts/Posters
- Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classi...Leo I. Gordon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Mul...Leo I. Gordon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD EvaluationLeo I. Gordon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Inhibition of Pro-Survival Pathways in DLBCL Cells By Functional Lipoprotein-like Nanoparticles2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- A Phase II Studyof Sequential Pembrolizumab (PEM) Followed By AVD for Frontline Treatment of Classical Hodgkin Lymphoma (CHL): Quantifying Response Following PEM Monot...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Data from Phase 2 PILOT Study of Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Show Substantial Durable Responses in Patients with Refractory or Relapsed Large B-cell Lymphoma After First-Line TherapyMay 27th, 2022- New Alternative for Relapsed B-cell LymphomaJanuary 26th, 2022
Expert Discusses JCAR017 CAR T-cell Therapy in Non-Hodgkin LymphomaMarch 6th, 2017- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Northwestern Memorial HospitalChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
